Defining multidrug-resistant tuberculosis: Correlating GenoType MTBDRplus assay results with minimum inhibitory concentrations

Diagnostic Microbiology and Infectious Disease

Volumn 82, Issue 1, 2015, Pages 49-53

  Kambli, Priti ^a   Ajbani, Kanchan ^a   Sadani, Meeta ^a   Nikam, Chaitali ^a   Shetty, Anjali ^a   Udwadia, Zarir ^a   Georghiou, Sophia B ^b   Rodwell, Timothy C ^b   Catanzaro, Antonino ^b   Rodrigues, Camilla ^a  

^a P D HINDUJA NATIONAL HOSPITAL   (India)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Drug susceptibility testing; Level of resistance; Multidrug resistant tuberculosis; Mutations

Indexed keywords

AMIKACIN; CAPREOMYCIN; ISONIAZID; KANAMYCIN; QUINOLONE DERIVATIVE; RIFAMPICIN; BACTERIAL PROTEIN; CATALASE; DNA DIRECTED RNA POLYMERASE; INHA PROTEIN, MYCOBACTERIUM; KATG PROTEIN, MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASE; RNA POLYMERASE BETA SUBUNIT; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CORRELATION ANALYSIS; GENE MUTATION; GENOTYPE MTBDRPLUS ASSAY; INHA GENE; KATG GENE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DIAGNOSIS; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PYROSEQUENCING; QUANTITATIVE ANALYSIS; RPOB GENE; COMPARATIVE STUDY; DRUG EFFECTS; GENETICS; GENOTYPE; GENOTYPING TECHNIQUE; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE; MUTATION; PHENOTYPE; PROCEDURES; TUBERCULOSIS, MULTIDRUG-RESISTANT;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATALASE; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOTYPE; GENOTYPING TECHNIQUES; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OXIDOREDUCTASES; PHENOTYPE; RIFAMPIN; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84928356509     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2015.01.009     Document Type: Article

References (20)

1. Ajbani K., Nikam C., Kazi M., Gray C., Boehme C., Balan K., et al. Evaluation of GenoType MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sediments. PLoS One 2012, 7(11):e49433.
2. Gandhi N., Nunn P., Dheda K., Schaaf H., Zignol M., van Soolingen D., et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 2010, 375(9728):1830-1843.
3. Gracelin S.Y., Desmond E.P. Molecular diagnosis of tuberculosis and drug resistance. Clin Lab Med 2014, 34:297-314.
4. Guo H., Seet Q., Denkin S., Parsons L., Zhang Y. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA. J Med Microbiol 2006, 55:1527-1531.
5. Heifets L., Cangelosi G. Chapter 81: drug resistance assays for mycobacterium tuberculosis. Antimicrobial drug resistance infectious disease 2009, 1161-1170.
6. Jonsson G., Furin J. Will molecular diagnosis of drug-resistant tuberculosis improve patient outcomes?. Int J Tuberc Lung Dis 2012, 16(1):4-5.
7. Lin S.Y., Rodwell T., Victor T., Rider E., Pham L., Catanzaro A., et al. Pyrosequencing for rapid detection of extensively drug-resistant mycobacterium tuberculosis in clinical isolates and clinical specimens. J Clin Microbiol 2014, 52(2):475-482.
8. Rigouts L., Gumusboga M., de Rijk W.B., Nduwamahoro E., Uwizeye C., de Jong B., et al. Rifampin resistance missed in automated liquid culture system for Mycobacterium tuberculosis isolates with specific rpoB mutations. J Clin Microbiol 2013, 51(8):2641-2645.
9. Santos L.C. Review: the molecular basis of resistance in Mycobacterium tuberculosis. Open Indian J Med Microbiol 2012, 2:24-36.
10. Shah N., Richardson J., Moodley P., Moodley S., Babaria P., Ramtahal M., et al. Increasing drug resistance in extensively drug-resistant tuberculosis, South Africa. Emerg Infect Dis 2011, 17(3):510-513.
11. Siddiqi S., Gerdes R. MGIT procedure manual: for Bactec MGIT 960 TB System 2006, FIND Diagnostics, [cited 2012 12 December; Available from: http://www.finddiagnostics.org/export/sites/default/resource-centre/find_documentation/pdfs/mgit_manual_nov_2007.pdf].
12. Sirgel F., Warren R., Böttger E., Klopper M., Victor T., Helden P. The rationale for using rifabutin in the treatment of MDR and XDR tuberculosis outbreaks. PLoS One 2013, 8(3):1-4.
13. Springer B., Calligaris-Maibach R., Ritter Claudia, Bottger E. Tuberculosis drug resistance in an area of low endemicity in 2004 to 2006: semiquantitative drug susceptibility testing and genotyping. J Clin Microbiol 2008, 46(12):4064-4067.
14. Springer B., Lucke K., Calligaris-Maibach R., Ritter C., Bottger E. Quantitative drug susceptibility testing of mycobacterium tuberculosis by use of MGIT 960 and Epicenter Instrumentation. J Clin Microbiol 2009, 47(6):1773-1780.
15. Udwadia Z., Amale R., Ajbani K., Rodrigues C. Totally drug-resistant tuberculosis in India. Clin Infect Dis 2012, 54(4). [579-U156].
16. Velayati A., Masjedi M., Farnia P., Tabarsi P., Ghanavi J., Ziazarifi A., et al. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran. Chest 2009, 136(2):420-425.
17. World Health Organization (WHO) Molecular line probe assays for rapid screening of patients at risk of multi-drug resistant tuberculosis (MDR-TB): expert group report 2008, World Health Organization, [updated 2008; cited 2008a; Available from: http://www.who.int/tb/features_archive/expert_group_report_june08.pdf].
18. World Health Organization (WHO) Policy guidance on drug susceptibility testing (DST) of second-line antituberculosis drugs 2008, World Health Organization, [updated 2008; cited 2008; Availablefrom: http://whqlibdoc.who.int/hq/2008/WHO_HTM_TB_2008.392_eng.pdf].
19. World Health Organization (WHO) Multidrug and extensively drug-resistant TB (M/XDR-TB): 2010 global report on surveillance and response 2010, World Health Organization, [updated 2010;cited2011March,6; Availablefrom: http://whqlibdoc.who.int/publications/2010/9789241599191_eng.pdf].
20. World Health Organization (WHO) Global tuberculosis control: WHO report 2011 2011, World Health Organization, [updated 2011; cited 2011 March, 6; Available from: http://www.who.int/tb/publications/global_report/2011/gtbr11_full.pdf].